US FDA to allow mixing and matching of COVID-19 boosters: Report

The US Food and Drug Administration (FDA) is planning to allow Americans to get a different booster shot of a COVID-19 vaccine than the one initially taken, the New York Times reported on Monday (Oct 18). 

The FDA in September authorised a booster dose of Pfizer and partner BioNTech’s two-shot COVID-19 vaccine for those aged 65 and older and some high-risk Americans.

The regulator’s advisory panel has also backed the use of Moderna and Johnson & Johnson’s COVID-19 vaccine booster shots.

The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said, citing people familiar with the agency’s plans.


See also  Asian Insider, March 17: Malaysia under movement control, Taiwan scrambles jets, again, deepfake videos in India’s elections, two bombs in Yala province

Leave a Reply